<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_11-12_643</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.643</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Arrhythmias</subject></subj-group>
</article-categories>
<title-group>
<article-title>Our experience with pulmonary vein isolation using irreversible electroporation - &#x201C;pulsed field ablation&#x201D;</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-6233-656X</contrib-id><name><surname>&#x017D;deri&#x0107;</surname><given-names>Martina</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9951-9077</contrib-id><name><surname>&#x0160;ari&#x0107;</surname><given-names>Mirela</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-1673-5430</contrib-id><name><surname>Bukovski</surname><given-names>Petra</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-8334-032X</contrib-id><name><surname>Udiljak</surname><given-names>Glorija</given-names></name></contrib>
<aff id="aff1"><institution>University Hospital Centre &#x201C;Sestre milosrdnice&#x201D; Zagreb</institution>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Martina &#x017D;deri&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Sestre milosrdnice, Vinogradska cesta 29, HR-10000 Zagreb, Croatia. / Phone: +385-99-5728-407 / E-mail: <email xlink:href="mzderic15@gmail.com">mzderic15@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>11-12</issue>
<fpage>643</fpage>
<lpage>643</lpage>
<history>
<date date-type="received"><day>27</day><month>09</month><year>2024</year></date>
<date><day>31</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>irreversible electroporation</kwd><kwd>atrial fibrillation</kwd><kwd>experience</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Pulsed field ablation or irreversible electroporation is a newer method in the ablation treatment of cardiac arrhythmias. The first atrial fibrillation ablation procedure using pulsed electric fields at the Department of Arrhythmias, University Hospital Centre &#x201C;Sestre milosrdnice&#x201D;, was successfully performed in September 2023. By July 2024, a total of 74 patients successfully underwent pulsed electric field ablation. Of these, 59.46% had paroxysmal atrial fibrillation, while 40.54% had persistent atrial fibrillation. In 100% of patients, the desired acute outcome was achieved by isolating the entrances of all pulmonary veins. Follow-up showed atrial fibrillation recurrence in 13.5% of patients, comparable to data from the literature. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) Patients from various age groups underwent the procedure, the average age of women is 59 years and of men 68 years. Regarding gender distribution, men predominate (74%), consistent with global trends, which can be explained by the fact that women are referred for ablation treatment later in life. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) The procedure lasted an average of 48 minutes and 22 seconds. The overall complication rate was 10%, with most being vascular - hematoma or prolonged bleeding at the puncture site, which required only conservative treatment, such as prolonged compression (up to 12 hours). An A-V fistula requiring surgical treatment occurred in 1.3% patient. For the successful treatment of atrial fibrillation patients, timely detection is crucial, as early-stage treatment offers the highest success rate (up to 80%). Pulsed electric field ablation, as a new method, represents a significant step forward in the treatment of atrial fibrillation, which will improve the quality of patient care. In this paper, we presented the experiences at the University Hospital Center &#x201C;Sestre milosrdnice&#x201D; in applying this new treatment method, showing that our results are comparable to those from other electrophysiology centers. It is important to emphasize that role of nurse is essential. Together with doctor, she provides healthcare during hospitalization. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) Our experiences with pulsed electric field ablation in the treatment of atrial fibrillation have been extremely positive. Due to the fact that this is a highly effective procedure with a low rate of procedural complications.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shtembari</surname><given-names>J</given-names></name><name><surname>Shrestha</surname><given-names>DB</given-names></name><name><surname>Pathak</surname><given-names>BD</given-names></name><name><surname>Dhakal</surname><given-names>B</given-names></name><name><surname>Upadhaya Regmi</surname><given-names>B</given-names></name><name><surname>Patel</surname><given-names>NK</given-names></name><etal/></person-group> <article-title>Efficacy and Safety of Pulsed Field Ablation in Atrial Fibrillation: A Systematic Review.</article-title> <source>J Clin Med</source>. <year>2023</year> January 16;<volume>12</volume>(<issue>2</issue>):<fpage>719</fpage>. <pub-id pub-id-type="doi">10.3390/jcm12020719</pub-id><pub-id pub-id-type="pmid">36675649</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chibber</surname><given-names>T</given-names></name><name><surname>Baranchuk</surname><given-names>A</given-names></name></person-group>. <article-title>Sex-Related Differences in Catheter Ablation for Patients With Atrial Fibrillation and Heart Failure.</article-title> <source>Front Cardiovasc Med</source>. <year>2020</year> December 14;<volume>7</volume>:<elocation-id>614031</elocation-id>. <pub-id pub-id-type="doi">10.3389/fcvm.2020.614031</pub-id><pub-id pub-id-type="pmid">33381530</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="book">Saunorus Baird M, Keen JH, Swearingen L. Manual of critical care nursing: nursing interventions and collaborative management. 5th ed. St. Louis (MO): Elsevier-Mosby; 2005.</mixed-citation></ref>
</ref-list>
</back>
</article>
